Compound Detail
CHEMBL10835
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL10835 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZDPIZPXVHVYTOK-UHFFFAOYSA-N |
13
Targets
28
Activities
2
Assay Types
2
PK Parameters
20
Publications
0
Known Names
Molecular Properties
350.0
MW (Da)
5.94
ALogP
1
HBA
2
HBD
41.1
PSA (Ų)
0.69
QED
1
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 24 meas. best 7.55
EC50 4 meas. best 6.34
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Bifunctional epoxide hydrolase 2 CHEMBL2409 | IC50 | 7.55 | 7.55 | 28.1 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.68 | 5.9375 | 210.0 | 4 |
| Epoxide hydrolase 1 CHEMBL1968 | IC50 | 6.58 | 6.58 | 260.0 | 1 |
| Plasmodium falciparum CHEMBL364 | EC50 | 6.34 | 6.0425 | 460.0 | 4 |
| Epoxide hydrolase 1 CHEMBL1075293 | IC50 | 6.16 | 6.16 | 700.0 | 1 |
| Schistosoma mansoni CHEMBL612893 | IC50 | 6.1 | 5.8433 | 800.0 | 3 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 6.0 | 5.81 | 1000.0 | 2 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.69 | 5.55 | 2024.1 | 2 |
| Trypanosoma brucei rhodesiense CHEMBL612348 | IC50 | 5.66 | 5.66 | 2166.5 | 1 |
| Schistosoma japonicum CHEMBL612644 | IC50 | 5.66 | 5.51 | 2200.0 | 4 |
| Trypanosoma brucei brucei CHEMBL612851 | IC50 | 5.6 | 5.6 | 2499.1 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 5.42 | 5.42 | 3815.4 | 1 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 5.4 | 5.4 | 3970.0 | 2 |
| Leishmania infantum CHEMBL612848 | IC50 | 4.98 | 4.98 | 10556.1 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Cmax | 4400.0 | nM | Mus musculus |
| T1/2 | 4.7 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3301486 | Unchecked | 8 |
| - | 10.6019/CHEMBL3301472 | Human immunodeficiency virus 1 | 7 |
| - | 10.6019/CHEMBL3301472 | NON-PROTEIN TARGET | 6 |
| - | 10.6019/CHEMBL2094260 | Mycobacterium tuberculosis | 4 |
| - | 10.6019/CHEMBL3137381 | Onchocerca lienalis | 4 |
| - | 10.6019/CHEMBL3301464 | Unchecked | 4 |
| 26856921 | 10.1016/j.bmcl.2016.01.075 | Schistosoma japonicum | 4 |
| 30523084 | 10.1126/science.aat9446 | Plasmodium berghei | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 22153346 | 10.1016/j.bmcl.2011.10.126 | NON-PROTEIN TARGET | 3 |
| - | 10.6019/CHEMBL2363022 | Schistosoma mansoni | 3 |
| - | 10.6019/CHEMBL3301546 | Saccharomyces cerevisiae | 3 |
| - | 10.6019/CHEMBL2028040 | Plasmodium falciparum | 3 |
| 33479649 | 10.1039/D0MD00062K | Schistosoma mansoni | 3 |
| 29317164 | 10.1016/j.bmcl.2017.12.064 | Schistosoma mansoni | 3 |
| 29317164 | 10.1016/j.bmcl.2017.12.064 | Mus musculus | 2 |
| - | 10.6019/CHEMBL3301458 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 2 |
| - | 10.6019/CHEMBL3301451 | Plasmodium falciparum | 2 |
| 30523084 | 10.1126/science.aat9446 | HepG2-CD81 | 2 |
| 18579783 | 10.1073/pnas.0802982105 | Plasmodium falciparum | 2 |
Data from ChEMBL 36 via Core Engine